Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-31, Stock:LLY, The news for the past five days is as follows:
2019-07-24: NEWS1: Eli Lilly (LLY) to Report Q2 Earnings: What's in Store?.NEWS2: Eli Lilly (LLY) to Report Q2 Earnings: What's in Store?.NEWS3: Eli Lilly (LLY) to Report Q2 Earnings: What's in Store?.
2019-07-25: NEWS1: Eli Lilly (LLY) Stock Down 6.8% in 2019: Can Q2 Earnings Boost Performance?.NEWS2: The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug.NEWS3: UPDATE 1-Eli Lilly's hypoglycemia treatment wins FDA approval.NEWS4: BAQSIMI™ (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA.
2019-07-26: NEWS1: Pharma Stock Roundup: GSK, BMY Q2 Earnings, FDA Nod to LLY's Hypoglycemia Treatment.NEWS2: Pharma Stock Roundup: GSK, BMY Q2 Earnings, FDA Nod to LLY's Hypoglycemia Treatment.NEWS3: Senate advances bill to cut the cost of prescriptions.NEWS4: EMA panel recommends approving Bayer's cancer drug Vitrakvi.NEWS5: Eli Lilly (LLY) Stock Down 6.8% in 2019: Can Q2 Earnings Boost Performance?.NEWS6: Eli Lilly (LLY) Stock Down 6.8% in 2019: Can Q2 Earnings Boost Performance?.
2019-07-29: NEWS1: Pre-Market Earnings Report for July 30, 2019 :  PG, MA, PFE, MRK, LLY, MO, COP, ECL, MMC, HCA, ETN, PEG.NEWS2: Pre-Market Earnings Report for July 30, 2019 :  PG, MA, PFE, MRK, LLY, MO, COP, ECL, MMC, HCA, ETN, PEG.NEWS3: Pfizer to Combine Off-Patent Drug Business With Mylan.NEWS4: Q2 Earnings Preview For Eli Lilly.NEWS5: Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up.NEWS6: Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up.NEWS7: Should You Buy Eli Lilly (LLY) Ahead of Earnings?.NEWS8: Should You Buy Eli Lilly (LLY) Ahead of Earnings?.NEWS9: What's in Store for Array BioPharma (ARRY) in Q4 Earnings?.NEWS10: What's in Store for Array BioPharma (ARRY) in Q4 Earnings?.NEWS11: Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up.NEWS12: What's in Store for Array BioPharma (ARRY) in Q4 Earnings?.NEWS13: Should You Buy Eli Lilly (LLY) Ahead of Earnings?.NEWS14: Is Eli Lilly (NYSE:LLY) A Risky Investment?.
2019-07-30: NEWS1: Here's What You'll Want to Know About Incyte's Impressive Q2 Results.NEWS2: Here's What You'll Want to Know About Incyte's Impressive Q2 Results.NEWS3: Eli Lilly's Solid Q2 Results: What You'll Want to Know.NEWS4: Eli Lilly's Solid Q2 Results: What You'll Want to Know.NEWS5: Why Pharma Giant Merck Expects Its Best Sales Growth In 9 Years.NEWS6: Eli Lilly&apos;s Solid Q2 Results: What You&apos;ll Want to Know.NEWS7: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS8: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS9: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS10: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS11: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS12: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS13: Merck Shares Rise on Strong Sales Growth.NEWS14: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS15: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS16: Economic and Earnings Date Deluge.NEWS17: Economic and Earnings Date Deluge.NEWS18: 6 Stock Gurus See Bargains Amid Market Highs.NEWS19: Economic and Earnings Date Deluge.NEWS20: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS21: Eli Lilly (LLY) Tops Q2 Earnings Estimates.NEWS22: Eli Lilly (LLY) Tops Q2 Earnings Estimates.NEWS23: Health Care Sector Update for 07/30/2019: FMS, MRK, LLY, JNJ, PFE, ABT, AMGN.NEWS24: Health Care Sector Update for 07/30/2019: FMS, MRK, LLY, JNJ, PFE, ABT, AMGN.NEWS25: Eli Lilly tops profit estimates on boost from diabetes drugs.NEWS26: Eli Lilly lifts outlook after boost from diabetes drug.NEWS27: Eli Lilly Reports Q2 Earnings Beat.NEWS28: Eli Lilly (LLY) Tops Q2 Earnings Estimates.NEWS29: Eli Lilly Tops Q2 Profit Forecast, Lifts 2019 Guidance, as Trulicity Sales Surge.NEWS30: The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings.NEWS31: UPDATE 3-Newer drugs help Eli Lilly top Wall Street quarterly profit estimate.NEWS32: Eli Lilly tops revenue estimates on diabetes drug boost.NEWS33: Eli Lilly's stock jumps after profit and revenue beats, raised guidance.NEWS34: Lilly Reports Second-Quarter 2019 Financial Results, Raises 2019 EPS Guidance.NEWS35: Lilly's Verzenio® (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2.

Answer: Rise